FSRA Health Service Provider (HSP) Stakeholder Advisory Committee (Committee) meeting with the Board of Directors

Summary of the meeting of May 5, 2023
25 Sheppard Avenue West  

Stakeholder Advisory Committee members present:

Sabrina Chagani – Intact Insurance
David Dos Santos – Hamilton Health Services
Elizabeth Leyland – Wawanesa Insurance
Avi Orner – Canadian Society of Medical Evaluators
John Spirou – C.A.R.E Institute
Elliott Steinberg – G.E.M.S Chiropractic and Rehabilitation Clinic
Lynn Whitehead – TD Insurance
Nizar Mahomed – Arthur Health

Board members present:

Joanne De Laurentiis – Chair of the Board
Joseph Iannicelli – Director
Kathy Bouey – Director

Management members present:

Mark White – Chief Executive Officer 
Huston Loke – Executive Vice President, Market Conduct
Jordan Solway – Executive Vice President, Legal and Enforcement
Heather Greenberg – Corporate Secretary and Deputy General Counsel
Erica Hiemstra – Head, Insurance Conduct
Wendy Horrobin – Head, Licensing and Risk Assessment
Chris Georgakopoulos – Director, Auto Policy
Dan Miles – Director, Corporate Communications
Stevie Madder – Senior Manager, Market Conduct - P&C Insurance
Kevin Liu – Technical Lead, Market Conduct

General comments

The Chair of the Board welcomed the Committee to the meeting and provided introductory remarks about the importance of sector engagement. She noted that the aim was to focus on issues of strategic importance and that the Board values the advice the Committee provides. 

The Executive Vice-President, Market Conduct, FSRA, provided introductory remarks relating to the function of the Committee on providing the Board with direct feedback on supervision of the HSP Framework, along with emphasizing the important work members engage in restoring people back to health. Furthermore, FSRA’s activities in the sector were highlighted, such as the advancement of education in the sector, the possibility of coordinating with various health regulatory colleges, and the use of risk-informed supervision. 

The Committee was asked to comment on factors FSRA should consider related to supervision of HSP business practices and billing in Health Claims for Auto Insurance (HCAI), key market conduct risks for HSPs, and critical factors in increasing compliance in the HSP sector. Common themes discussed included, but were not limited to:

  • FSRA’s role in educating the sector and how focussing on education will help create better practices in the industry and support FSRA’s compliance-based approach. 
  • Improving HCAI data for data quality and accuracy purposes as HCAI data can be very beneficial to addressing fraud, but current issues around data quality are hindering its efficiency.
  • Creating better communication avenues with health regulatory colleges will be a good step in terms of data sharing, but there also needs to be greater clarity between the roles and responsibilities of colleges and the regulator. 
  • While outside FSRA’s scope, members discussed and raised concerns around auto reform and the need to develop and implement up-to-date programs of care.
  • Establishing forums/working groups to focus on issues that fall outside of the Committee’s scope.

The Chair thanked the Committee for their insight and helping the Board focus on the strategic issues for the sector, and for raising awareness of the current pain points. The Executive Vice-President, Market Conduct, FSRA, thanked the Committee and emphasized FSRA’s scope and mandate related to the sector. FSRA will continue to direct Committee members to the appropriate ministries, regulators and committees for all issues that fall outside of the scope of the Committee. The Chief Executive Officer, FSRA, also thanked the Committee for providing valuable input and appreciated how complex these issues are.